4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-010281
Chief Scientific Officer sold 14,235 shares at $0.88 ($12,552)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Taveras Arthur Chief Scientific Officer | 2024-03-11 | Sale | −14,235 | $0.88 | $12,552 | 234,301 | D |
| Open-market sales · 14,235 sh · avg $0.88 · $12,552 | |||||||
Loading xslF345X05/wk-form4_1710192010.xml…